AUA 2011 - The natural history of ultrasensitive PSA following radical prostatectomy - Session Highlights
WASHINGTON, DC USA (UroToday.com) - The first detectable ultrasensitive PSA (uPSA) was the strongest predictor of treatment failure after radical prostatectomy (RP) according to this report from UCLA.
AUA 2011 - Uniform anatomic template for pelvic lymph node dissection during radical prostatectomy: Comparison of open, laparoscopic and robot-assisted procedures - Session Highlights
WASHINGTON, DC USA (UroToday.com) - This presentation suggests that pelvic lymph node dissection (PLND) for prostate cancer can be performed with similar quality by open retropubic radical prostatectomy (ORP), laparoscopic radical prostatectomy (LRP), or robot-assisted laparoscopic prostatectomy (RALP).
AUA 2011 - Urologic malignancies in children – long term implications for adults - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Dr. Michael Ritchey focused on the long-term risks of secondary neoplasms, secondary gu malignancies, impact on fertility, renal failure and bladder dysfunction in children with a history of treated urologic malignancies.
AUA 2011 - Agent Orange linked to renal cancer - Press Release
WASHINGTON, DC USA (UroToday.com) - May 14, 2011 -
AUA 2011 - SBUR/SUO: A practical approach to managing patients with kidney tumors - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Dr. Robert Uzzo presented 4 thoughts for improving care of patients with kidney cancer.
AUA 2011 - SBUR/SUO: Debate: Laparoscopic vs. open retroperitoneal lymph node dissection - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Dr. Richard Foster argued for open retroperitoneal lymph node dissection (RPLND).
AUA 2011 - SBUR/SUO: Updates on novel therapies for advanced prostate cancer - Session Highlights
AUA 2011 - Gay men more vulnerable to quality of life impacts following prostate cancer - Press Release
WASHINGTON, DC USA (UroToday.com) - May 14, 2011 -
Survey data on health-related quality of life reveal lower than average scores for gay men who have had prostate cancer
AUA 2011 - Researchers study options in treating kidney cancer - Press Release
WASHINGTON, DC USA (UroToday.com) - May 14, 2011 -
AUA 2011 - SBUR/SUO: Case management panel: Adjuvant vs. salvage radiation: Role of decision analysis - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Dr. Ian Thompson argued for adjuvant radiotherapy (XRT) for prostate cancer after surgery.
AUA 2011 - SBUR/SUO: Case management panel: Approaches to the small renal mass observation - Session Highlights
AUA 2011 - SBUR/SUO: Chemotherapy resistant bladder cancer - Session Highlights
WASHINGTON, DC USA (UroToday.com) - This group identified 234 candidate suppressor genes and focused on RhoGDI2.
AUA 2011 - SBUR/SUO: Chemotherapy resistant breast cancer - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Dr. Sara Sukumar discussed chemotherapy resistant mechanisms in breast cancer.
AUA 2011 - SBUR/SUO: Docetaxel inhibits AR nuclear localization and activity - Session Highlights
AUA 2011 - SBUR/SUO: Grassroots collaborations to improve quality in urologic oncology - Session Highlights
AUA 2011 - SBUR/SUO: Improving the quality of bladder cancer care: Personalizing care through molecular-based research - Session Highlights
WASHINGTON, DC USA (UroToday.com) - This process begins with neo-adjuvant chemotherapy, which downstages bladder cancer in 40% and improves survival in their series.
AUA 2011 - SBUR/SUO: Improving the value of PSA - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Prostate cancer detection is closely linked to treatment in the US.
AUA 2011 - SBUR/SUO: Mechanisms of resistance to pro-apoptotic therapies - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Apoptosis maintains homeostasis in developing and normally developed cells.